Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial (Q35007696)

5 August 2017

Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

5 August 2017

0 references

1 reference

1 reference

1 reference

Manal F Abdelmalek

1

1 reference

5 August 2017

Schuyler O Sanderson

2

1 reference

5 August 2017

Paul Angulo

3

1 reference

5 August 2017

Consuelo Soldevila-Pico

4

1 reference

5 August 2017

Chen Liu

5

1 reference

5 August 2017

Joy Peter

6

1 reference

5 August 2017

Jill Keach

7

1 reference

5 August 2017

Matt Cave

8

1 reference

5 August 2017

Theresa Chen

9

1 reference

5 August 2017

Craig J McClain

10

1 reference

5 August 2017

Keith D Lindor

11

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

5 August 2017

1 reference

5 August 2017

50

1 reference

5 August 2017

1818-1826

1 reference

5 August 2017

6

1 reference

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

5 August 2017

1 reference

Betaine, metabolic by-product or vital methylating agent?

21 January 2018

1 reference

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

A simple rapid immunoassay for S-adenosylhomocysteine in plasma

21 January 2018

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Folate deficiency, methionine metabolism, and alcoholic liver disease

21 January 2018

1 reference

Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline

21 January 2018

1 reference

Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway

21 January 2018

1 reference

Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice

21 January 2018

1 reference

Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis

21 January 2018

1 reference

Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor

21 January 2018

1 reference

Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease

21 January 2018

1 reference

7 January 2021

Alleviation of dietary cirrhosis by betaine and other lipotropic agents

1 reference

7 January 2021

Betaine dose and treatment intervals in therapy for homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency

1 reference

7 January 2021

High-performance liquid chromatographic analysis of synthetic peptides using derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate

1 reference

7 January 2021

Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration

1 reference

7 January 2021

Betaine lowers elevated s-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23239

1 reference

5 August 2017

1 reference